Washington, D.C.—Today the U.S. Food and Drug Administration (FDA) failed to meet its court-ordered deadline to rule on all e-cigarette and other tobacco product manufacturers’ applications to keep their harmful products on the market.
Washington, D.C. — Enviamos nuestros mejores deseos a la senadora Amy Klobuchar, demócrata de Minnesota, mientras comparte su experiencia personal con el cáncer de mama en etapa inicial. Las declaraciones recientes de la senadora Klobuchar sobre la importancia de las pruebas de detección de rutina y el seguimiento son recordatorios de que la detección temprana del cáncer puede brindar la mejor oportunidad para un tratamiento exitoso.
More than a dozen patient advocacy organizations are commending the House Ways and Means Committee as it begins considering details of legislation to create the country’s first ever national paid family and medical leave program as part of the budget reconciliation package.
The American Cancer Society Cancer Action Network (ACS CAN) is calling on the Departments of Health and Human Services, Labor and Treasury to put cancer patients and survivors first when implementing rules around surprise medical bills.
The U.S. Food and Drug Administration issued marketing denial orders (MDOs) to 31 companies who sought to sell 300,000 flavored electronic cigarettes. The decision requires these manufacturers to remove those identified products already on the market.
The U.S. Food and Drug Administration issued its first denials of flavored electronic cigarettes after the agency determined the manufacturer’s products pose a greater risk to public health than any potential benefit.
Washington, D.C. — La ley DIVERSE para ensayos clínicos (DIVERSE Trials Act), presentada tanto en la Cámara de Representantes como en el Senado, aumentaría la diversidad en los ensayos clínicos y facilitaría la participación de todos los pacientes con cáncer en ensayos clínicos. La legislación bipartidista y bicameral, respaldada por los Senadores Robert Menendez (D-N.J.) y Tim Scott (R-S.C.), y los Representantes Raul
Today the president called on Congress to bring down patient prescription drug costs, an issue of critical importance to cancer patients. Among the provisions the president outlined was establishing an annual cap on Medicare enrollees’ out-of-pocket expenses.
Late last week the administration rescinded a proposed rule that would have tied the price of select Medicare Part B drugs to that of foreign countries. Of the 50 drugs selected for participation under the Most Favored Nation rule, 35 would have been cancer drugs.
More than two dozen patient groups and health care partners are joining forces to call for a comprehensive paid family and medical leave program, including caregiving leave.